Peachtree Attends the World Orphan Drug Conference 2020

Peachtree attends the World Orphan Drug Conference 2020, November 2-5 at 9:00 CET.

Join Peachtree as we explore the pressing challenges and unique opportunities to develop rare disease therapeutics.

Rare disease studies require more individualized proactive approaches. Aside from ensuring that the selected sites are qualified and have access to the subject population, you have to start with the basic tenet of, "where does the subject population go to seek information about their illness?" It is from this basis that recruitment/retention specialists develop a customized program - a combination of internal resources and partnerships with specialized vendors – that seeks to leverage site subject data, access subjects at multiple touchpoints and provide in-trial support for retention.

To learn more, visit the Orphan Drug Congress website or contact us via our Contacts form.

At Peachtree, we are the CRO that thinks like a Sponsor.

Peachtree's Steve Asche to Present at Georgia Bio Innovation

Peachtree's Steve Asche, Vice President, Clinical Operations, to Present at Georgia Bio Innovation Summit: Continuation of Clinical Research Study Activities!!

November 4th – 11:10 am – 12:00 pm EST Please join our discussion!

COVID-19 has lead the drug and device development industry down an unprecedented path. As an industry, we have evolved our processes to incorporate new strategies and adapt to this ever changing clinical trial landscape. New challenges, opportunities, and solutions have emerged as clinical trials and development quickly shift from in-person to remote support. As we continue working to identify and apply the best strategies, it is clear that we must embrace innovation. Areas of focus continue to be patient safety and advocacy, understanding and maintaining regulatory compliance, protocol and study design, quality, progressing clinical trial operations, and delivering therapies to patients. Please join us and many of your colleagues for our webinar focused on discussing solutions to Continuation of Clinical Research Activities Through the COVID-19 pandemic.

Peachtree is the CRO that thinks like a Sponsor.

Peachtree to attend CNS Summit 2020

CNS Solutions is where it all started for Peachtree. Peachtree emerged as we felt the current CRO dynamic wasn't successful at providing both what the patients, caregivers and sponsors needed. Even though we won’t be able to meet in person this year, we look forward to the diverse discussions and collaborations with other participants at the summit.

If you would like to learn more, visit the CNS Summit website and feel free to message us via our Contacts form.

At Peachtree, we are the CRO that thinks like a Sponsor.